Quinoflox 100 mg/ml Solution for Injection for Cattle and Pigs

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Enrofloxacin

Available from:

Global Vet Health S.L.

ATC code:

QJ01MA90

INN (International Name):

Enrofloxacin

Pharmaceutical form:

Solution for injection

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cattle, Pigs

Therapeutic area:

Antimicrobial

Authorization status:

Authorized

Authorization date:

2012-12-19

Summary of Product characteristics

Revised: November 2017
AN: 00172/2017
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Quinoflox 100 mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Enrofloxacin
100.0 mg
EXCIPIENTS:
Benzyl alcohol
0.02 ml
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear yellow solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CATTLE
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible
strains of _Pasteurella multocida, Mannheimia haemolytica _and
_Mycoplasma _spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible
strains of _Escherichia coli_.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia _
_coli_.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible
strains of _Mycoplasma bovis _in cattle less than 2 years old.
PIGS
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible
strains
of
_Pasteurella _
_multocida, _
_Mycoplasma _
spp.
and
_Actinobacillus _
_pleuropneumoniae. _
Treatment of infections of the urinary tract caused by enrofloxacin
susceptible
strains of _Escherichia coli. _
Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome)
caused by
enrofloxacin susceptible strains of _Escherichia coli _and _Klebsiella
_spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible
strains of _Escherichia coli_.
Revised: October 2014
AN: 00872/2014
Page 2 of 7
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia _
_coli_.
4.3
CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in growing horses because of possible deleterious damage on
articular
cartilage.
Do not use in animals with central nerv